News & Events

Event





GROW® – Online 'Meet the Management' Event

Thursday, 6 October, 2022
from 12:30 pm

[Registered investors only]

Growthdeck is pleased to offer our investor network the opportunity to participate in a £1.3m EIS-qualifying "pre-IPO" raise for British biopharmaceutical company Grow Group Plc.

In 2018 the British Government legalised the use of medical cannabis in the UK. Ahead of this announcement in 2017 Ben Langley co-founded Grow Group Plc and, with this first-mover advantage, it is now the UK's leading distributor with over 50% market share by sales.

Prescribed by healthcare professionals as an alternative to opioids to treat chronic conditions (including cancer, arthritis, anxiety and Alzheimer's disease), today the company distributes to >80 clinicians and helps >3,000 patients in the UK every month.
 
The company has an integrated approach to its operations across distribution, education, R&D and international trading, and intends to use the funding to scale-up existing UK operations and expand its highly-successful business model across Europe.

 

We would like to invite you to meet the core team at our online ‘meet the management’ session on Thursday 6th October to learn more about them and the opportunity.


Please join the network or log in to watch the Webinar & Q&A Recording.


This will be a 15-minute presentation, followed by a Q&A session, with:

Ben Langley (CEO & Co-Founder) — European cannabis thought leader, one of the UK's first professional Cannabis investors in 2016. Previously spent 12 years as an Investment Banker at JPMorgan specialising in commodities and natural resources.

Ian Atkinson (CSO & Co-Founder) — world-class geneticist and botanist with decades of R&D leadership experience. Co-Founder of Cannabis research company Lunaverse, and of medical device company Innovative Trauma Care. Combined PhD in Plant Molecular Biology and Biochemistry.

Pierre van Weperen (CEO, Grow Pharma) — operational and strategic leader with significant successes in running £50–£200m businesses both in the pharmaceutical industry and services.

Kalad Shah (CFO) — FCCA qualified accountant with 20+ years experience in strategic and financial planning.

 

 

Please register below if you would like to join us and we will send you the Zoom link.


Location: Online